RxDoctor Payments DataLook up a doctor →

Todd Viccione, MD

Internal Medicine · East Greenwich, RINPI 1356338073

Payments from drug & device makers

$22,462in general payments, 2019–2025

Across 1,296 payments — averaging $17.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • AbbVie$2K
  • Pfizer$2K
  • Boehringer Ingelheim$2K
  • Johnson & Johnson$2K
  • Novo Nordisk$2K
  • plus $10K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca133$2,872
AbbVie(2 entities)169$2,475
Pfizer201$2,123
Boehringer Ingelheim59$1,751
Johnson & Johnson(2 entities)87$1,687
Novo Nordisk100$1,626
GSK62$1,007
Lilly USA, LLC47$727
Exact Sciences23$457
Astellas Pharma US Inc17$391
Abbott20$376
Antares Pharma, Inc.18$328
E.r. Squibb & Sons, L.L.C.20$327
Merck39$326
Eisai Inc.20$290
ADC Therapeutics America, Inc.7$268
Teva Pharmaceuticals USA, Inc.16$259
Phathom Pharmaceuticals, Inc.12$239
Bayer9$228
Rigel Pharmaceuticals, Inc.6$227
Mirati Therapeutics, Inc.7$226
Amarin Pharma, Inc.11$214
Nestle Healthcare Nutrition Inc.8$214
Inspire Medical Systems, Inc.8$214
Incyte Corporation10$209
Takeda Pharmaceuticals U.S.A., Inc.18$200
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC11$197
Tolmar, Inc.10$197
Mylan Specialty L.p.9$195
Taiho Oncology, Inc.6$188
Biohaven Pharmaceuticals, Inc.12$188
Biohaven Pharmaceutical Holding Company Ltd.21$177
Amgen8$163
Sanofi-aventis U.S. LLC8$158
Mannkind Corporation1$131
Collegium Pharmaceutical, Inc.7$118
MDD US Operations, LLC5$108
Novartis3$85
Regeneron Healthcare Solutions, Inc.4$84
Hikma Pharmaceuticals USA5$80
Ardelyx, Inc.3$73
Blueprint Medicines Corporation3$64
Kowa Pharmaceuticals America, Inc.4$62
Sobi, Inc3$60
Idorsia Pharmaceuticals US Inc3$58
Daiichi Sankyo Inc.3$56
Exelixis Inc.2$56
Melinta Therapeutics, LLC3$54
Ironwood Pharmaceuticals, Inc3$53
Paratek Pharmaceuticals, Inc.3$48
Gilead2$43
Jazz Pharmaceuticals Inc.2$43
Morphosys, US Inc.2$43
Amneal Pharmaceuticals LLC2$40
Corcept Therapeutics1$33
Xeris Pharmaceuticals, Inc.2$33
Bausch Health US, LLC2$32
Agios Pharmaceuticals, Inc.2$32
Verity Pharmaceuticals Inc.1$30
Lundbeck LLC2$28

How this compares

$22,462 in reported general payments places this provider in the 95th percentile of 808 internal medicine providers in Rhode Island.

See all internal medicine providers in Rhode Island

Medicare billing

Part B allowed, 2024
$79,323
Medicare patients
276
Services billed
745

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in East Greenwich

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →